Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Up - What's Next?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient shares gapped up prior to trading, opening at $77.09, up from a previous close of $73.81.
  • Citigroup maintained a "neutral" rating on Eurofins Scient, with an overall average rating of "Hold" from analysts, including one Strong Buy rating.
  • The company has solid liquidity ratios, with a quick ratio of 1.19 and a current ratio of 1.26, while their two-hundred day moving average stands at $66.43.
  • MarketBeat previews top five stocks to own in October.

Shares of Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $73.81, but opened at $77.09. Eurofins Scient shares last traded at $77.09, with a volume of 150 shares trading hands.

Wall Street Analyst Weigh In

Separately, Citigroup reissued a "neutral" rating on shares of Eurofins Scient in a report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating and five have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold".

Check Out Our Latest Report on ERFSF

Eurofins Scient Stock Down 0.6%

The company has a quick ratio of 1.19, a current ratio of 1.26 and a debt-to-equity ratio of 0.77. The company has a 50 day moving average of $75.80 and a two-hundred day moving average of $66.43.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Eurofins Scient Right Now?

Before you consider Eurofins Scient, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eurofins Scient wasn't on the list.

While Eurofins Scient currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.